Martina Borghi

3.6k total citations · 3 hit papers
38 papers, 2.8k citations indexed

About

Martina Borghi is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Martina Borghi has authored 38 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Martina Borghi's work include Immunotherapy and Immune Responses (11 papers), Virus-based gene therapy research (9 papers) and HIV Research and Treatment (6 papers). Martina Borghi is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Virus-based gene therapy research (9 papers) and HIV Research and Treatment (6 papers). Martina Borghi collaborates with scholars based in Italy, Netherlands and United States. Martina Borghi's co-authors include Stefano Fais, Angelo De Milito, Giulietta Venturi, Mario Santinami, Mariantonia Logozzi, Licia Rivoltini, Cristina Federici, Luana Lugini, Veronica Huber and Daria Brambilla and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Martina Borghi

35 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients

2009 776 citations Mariantonia Logozzi, Angelo De Milito et al. PLoS ONE profile →
Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes

2012 490 citations Arianna Calcinotto, Paola Filipazzi et al. Cancer Research profile →
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

2021 222 citations Stefania Dispinseri, Massimiliano Secchi et al. Nature Communications profile →

Peers

Martina Borghi

IMMUN

ONCOL

Regina Heidenreich Germany

Massimo Spada Italy

Zhiliang Wang United States

Sonja I. Buschow Netherlands

Eisaku Kondo Japan

Rommel A. Mathias Australia

Joanne Yu Canada

Chi Man Tsang Hong Kong

Luigi Aurisicchio Italy

Qian Zhong China

Regina Heidenreich Germany

Martina Borghi

1.7k ×0.9

516 ×0.5

956 ×1.3

IMMUN

583 ×1.2

ONCOL

316 ×0.8

Citations per year, relative to Martina Borghi Martina Borghi (= 1×) peers Regina Heidenreich

Countries citing papers authored by Martina Borghi

Since Specialization

Citations

This map shows the geographic impact of Martina Borghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Borghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Borghi more than expected).

Fields of papers citing papers by Martina Borghi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Borghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Borghi. The network helps show where Martina Borghi may publish in the future.

Co-authorship network of co-authors of Martina Borghi

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Borghi. A scholar is included among the top collaborators of Martina Borghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Borghi. Martina Borghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pirillo, Maria Franca, Martina Borghi, Felicia Grasso, et al.. (2025). Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice. Vaccines. 13(3). 216–216. 1 indexed citations

Macchia, Iole, Valentina La Sorsa, Alessandra Ciervo, et al.. (2024). T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects. Biomolecules. 14(10). 1217–1217. 1 indexed citations

Dispinseri, Stefania, Vito Lampasona, Massimiliano Secchi, et al.. (2021). Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia. The Journal of Clinical Endocrinology & Metabolism. 106(5). 1472–1481. 35 indexed citations

Bona, Roberta, Zuleika Michelini, Andrea Canitano, et al.. (2021). Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization. Molecular Therapy — Methods & Clinical Development. 23. 263–275. 9 indexed citations

Borghi, Martina, Zuleika Michelini, Felicia Grasso, et al.. (2021). Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy. Viruses. 13(2). 355–355. 19 indexed citations

Dispinseri, Stefania, Massimiliano Secchi, Maria Franca Pirillo, et al.. (2021). Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nature Communications. 12(1). 2670–2670. 222 indexed citations breakdown →

Borghi, Martina, Maria Franca Pirillo, Serena Cecchetti, et al.. (2020). Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice. Molecular Therapy — Methods & Clinical Development. 17. 418–428. 13 indexed citations

Borghi, Martina, Roberta Bona, Felicia Grasso, et al.. (2018). Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens. Frontiers in Immunology. 9. 171–171. 32 indexed citations

Federici, Cristina, Francesco Petrucci, Stefano Caimi, et al.. (2014). Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin. PLoS ONE. 9(2). e88193–e88193. 295 indexed citations

10.

Rossi, Alessandra, Zuleika Michelini, Pasqualina Leone, et al.. (2014). Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector. PLoS ONE. 9(9). e107377–e107377. 11 indexed citations

11.

Calcinotto, Arianna, Paola Filipazzi, Matteo Grioni, et al.. (2012). Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes. Cancer Research. 72(11). 2746–2756. 490 indexed citations breakdown →

12.

Borghi, Martina, et al.. (2008). Análisis de las piezas de prostatectomía radical de pacientes con cáncer de próstata considerado de bajo potencial maligno. Revista Argentina de Urología. 73(1). 14.

13.

Delfino, Laura, Emanuela Zappia, Patrizia Castellani, et al.. (2008). The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants. International Journal of Cancer. 123(8). 1770–1778. 70 indexed citations

14.

Croce, Michela, Raffaella Meazza, Anna Maria Orengo, et al.. (2008). Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen. Cancer Immunology Immunotherapy. 57(11). 1625–1634. 28 indexed citations

15.

Baroncelli, Silvia, Donatella Negri, Roberto Belli, et al.. (2007). Characterization of α -Defensins Plasma Levels in Macaca Fascicularis and Correlations with Virological Parameters during SHIV89.6P _cy11 Experimental Infection. AIDS Research and Human Retroviruses. 23(2). 287–296. 5 indexed citations

16.

Buffa, Viviana, Donatella Negri, Pasqualina Leone, et al.. (2006). Evaluation of a Self-Inactivating Lentiviral Vector Expressing Simian Immunodeficiency Virus Gag for Induction of Specific Immune Responses in Vitro and in Vivo. Viral Immunology. 19(4). 690–701. 28 indexed citations

17.

Negri, Donatella, Viviana Buffa, Pasqualina Leone, et al.. (2004). Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses. Journal of Immunological Methods. 291(1-2). 153–163. 5 indexed citations

18.

Borghi, Martina, Corlien A. Aarnoudse, Menzo Havenga, et al.. (2003). CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame. The Journal of Immunology. 170(3). 1490–1497. 40 indexed citations

19.

Griffioen, Marieke, Martina Borghi, Peter I. Schrier, & Susanne Osanto. (2001). Detection and quantification of CD8+ T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-?-elispot assay. International Journal of Cancer. 93(4). 549–555. 28 indexed citations

20.

Elsas, Andrea van, et al.. (1996). Peptide‐pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA‐A*0201‐binding peptides from the Melan‐A/MART‐1 self antigen. European Journal of Immunology. 26(8). 1683–1689. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact